TALARIS THERAPEUTICS
Live / Registered — Registered (as of 20 Oct 2020)
What this means for you
Registered since 20 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88197017
- Registration number
- 6180755
- Mark type
- Stylized text
- Filed
- 16 Nov 2018
- Published for opposition
- 12 Nov 2019
- Registered
- 20 Oct 2020
- Attorney of record
- Maya L. Tarr
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations in the nature of allogeneic cell therapies for use in treating organ transplant patients
- Class 042 — Scientific and technological services: Providing laboratory services to hospitals and transplant centers involving manipulation of allogeneic cells used for cell therapy treatment of organ transplant patients
Owner
- TALARIS THERAPEUTICS, INC., LOUISVILLE, KY, US
- TALARIS THERAPEUTICS, INC., LOUISVILLE, KY, US
- Regenerex, Inc., Louisville, KY, US
- Regenerex, Inc., Louisville, KY, US
Prosecution history
- 20 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Sept 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Aug 2020 — USE AMENDMENT FILED
- 18 Aug 2020 — SOU EXTENSION 2 GRANTED
- 07 Aug 2020 — SOU EXTENSION 2 FILED
- 18 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Aug 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Aug 2020 — SOU TEAS EXTENSION RECEIVED
- 07 Aug 2020 — TEAS STATEMENT OF USE RECEIVED
- 08 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED